Adverse Event Contact, GMPs Send Foreign Supplement Firms To Import Alerts
This article was originally published in The Rose Sheet
Executive Summary
Products linked to both GMP and labeling problems were identified on "detention without physical examination" import alerts. Firms from Australia, Italy, Norway and Romania were added in FDA's latest alert update.
You may also be interested in...
Products Imported As Supplements Contain Anticonvulsants, Cholesterol Drugs
A July 15 import alert states that FDA and U.S. Customs officials can detain without physical examination certain imports from 20 foreign firms, including 14 from China.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.
US Health And Wellness People News: CHPA, Bayer, Viatris, Qnovia, Powerade
Sanofi consumer health scientific affairs lead moves to CHPA; change in Bayer’s US consumer health marketing helm; Viatris CCO moves from same post at Moderna; Qnovia expands scientific advisory board; and Powerade powers Girls Inc. scholarships, programs.